This map shows the geographic impact of D E Furst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Furst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Furst more than expected).
This network shows the impact of papers produced by D E Furst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Furst. The network helps show where D E Furst may publish in the future.
Co-authorship network of co-authors of D E Furst
This figure shows the co-authorship network connecting the top 25 collaborators of D E Furst.
A scholar is included among the top collaborators of D E Furst based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with D E Furst. D E Furst is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Huizinga, T., Seán Connolly, Alyssa Johnsen, et al.. (2015). Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate. Data Archiving and Networked Services (DANS). 67.1 indexed citations
4.
Song, Jae Yeol, et al.. (2015). A cautionary tale: dealing with missing data in clinical trials for rheumatic diseases.. PubMed. 32(6 Suppl 86). S–122.3 indexed citations
5.
Peterfy, Charles, Gerd R Burmester, V. DiCarlo, et al.. (2014). Sustained Improvements in Magnetic Resonance Imaging Outcomes with Abatacept Following the Withdrawal of All Treatment in Patients with Early Rheumatoid Arthritis. Data Archiving and Networked Services (DANS). 66.2 indexed citations
6.
Burmester, Gerd R, D E Furst, Bernard Combe, et al.. (2014). Stringent Criteria for Low Disease Activity and Remission after 12 Months of Treatment, and after Treatment Withdrawal, with Abatacept Monotherapy, Abatacept with Methotrexate or Methotrexate Alone in Early Rheumatoid Arthritis. Data Archiving and Networked Services (DANS). 66.4 indexed citations
7.
Huizinga, T., Seán Connolly, D E Furst, et al.. (2014). The Impact on Anti-Citrullinated Protein Antibody Isotypes and Epitope Fine Specificity in Patients with Early RA Treated with Abatacept and Methotrexate.. Data Archiving and Networked Services (DANS). 66.4 indexed citations
8.
Furst, D E, Gerd R Burmester, Bernard Combe, et al.. (2014). Patient-Reported Outcomes Following 12 Months of Therapy with Abatacept (Plus Methotrexate or as Monotherapy) or Methotrexate and up to 6 Months after Treatment Withdrawal in Patients with Early Rheumatoid Arthritis. Data Archiving and Networked Services (DANS). 66.2 indexed citations
Bingham, Clifton O., Christoph Pohl, Rieke Alten, et al.. (2009). “Flare” and disease worsening in rheumatoid arthritis: Time for a definition. UWE Research Repository (UWE Bristol).9 indexed citations
Genovese, Mark C., Shira Cohen, D E Furst, et al.. (2001). Safety Of Combination Therapy With Anakinra And Etanercept In Patients With Rheumatoid Arthritis.. Arthritis & Rheumatism. 44(9).23 indexed citations
Furst, D E, et al.. (1993). Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate.. PubMed. 20(8). 1297–302.18 indexed citations
19.
Furst, D E. (1988). Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications.. PubMed. 17. 58–62.20 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.